ALZ-801 is a potent and orally available small-molecule beta-amyloid (Abeta) anti-oligomer and aggregation inhibitor, valine-conjugated proagent of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound[1]. ALZ-801 is an advanced and markedly improved candidate for the treatment of alzheimers disease[2].
Molekulargewicht:
238.30
Reinheit:
98.83
CAS Nummer:
[1034190-08-3]
Formel:
C8H18N2O4S
Target-Kategorie:
Amyloid-beta
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten